MiniMed Group, Inc. MMED

Set alert

Price alert · MMED

All alert types
18.90 USD +0.62 +3.39%

At close · Nov 2

18.99 +0.09 +0.48%

After hours · Nov 2, 5:44 PM ET

Bid
18.90 × 2
Ask
18.91 × 2
18.20 Day range 19.03
10.65 52-week range 24.43
YTD
+2.22%
1 year
+2.22%
Open
18.38
Prev close
18.28
Mkt cap
5.32B
Vol
6.75M
Avg vol
7.21M
EPS
-1.59
P/E
0.00
Div yield
0.00%
More statistics
Low
18.20
High
19.03
Forward P/E
27.22
Beta
0.00
Short ratio
1.61
Inst. own
21.30%
Dividend
0.00
Ex-div date
Earnings
Dec 30, 2026
50-d avg
20.15
200-d avg
16.60
1y target
25.47

1D chart

Chart tools
Interval

Signals (53)
NameTimeAgo
MACD: Sell Signal3:58 PM9 hours ago
RSI: Overbought3:45 PM9 hours ago
MACD: Buy Signal3:42 PM9 hours ago
SMA: Bullish3:41 PM9 hours ago
SMA: Bearish3:33 PM9 hours ago
SMA: Bullish3:32 PM9 hours ago
SMA: Bullish3:32 PM9 hours ago
SMA: Bearish3:30 PM9 hours ago
SMA: Bearish3:30 PM9 hours ago
MACD: Sell Signal3:28 PM10 hours ago
RSI: Overbought3:21 PM10 hours ago
MACD: Buy Signal3:15 PM10 hours ago
MACD: Sell Signal3:03 PM10 hours ago
MACD: Buy Signal2:41 PM10 hours ago
SMA: Bullish2:27 PM11 hours ago
SMA: Bearish2:25 PM11 hours ago
SMA: Bearish2:24 PM11 hours ago
MACD: Sell Signal2:20 PM11 hours ago
MACD: Buy Signal2:11 PM11 hours ago
MACD: Sell Signal2:07 PM11 hours ago

Newest 20 of 53.

Key statistics

Market cap
5.32B
Enterprise value
5.00B
Trailing P/E
0.00
Forward P/E
27.22
PEG ratio
0.00
Price / sales
1.65
Price / book
1.47
EPS (TTM)
-1.53
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-9.74%
Revenue (TTM)
3.22B
Revenue growth
16.60%
Free cash flow
0
Total cash
207.00M
Total debt
59.00M
Return on equity
-8.66%
Shares outstanding
281.35M
Short % of float
72.56%
50-day average
20.15
200-day average
16.60

Financials — quick view

All financials
MMED Revenue — quarterly 843.00M
2025-Q3 20242025-Q4 20252026-Q1 20252026-Q3 20252026-Q4 20262027-Q1 2026
MMED Net income — quarterly 0
2025-Q3 20242025-Q4 20252026-Q1 20252026-Q3 20252026-Q4 20262027-Q1 2026
MMED EPS — quarterly 0.00
2025-Q3 20242025-Q4 20252026-Q1 20252026-Q3 20252026-Q4 20262027-Q1 2026

Earnings

MMED recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 30, 2026Oct 30, 20260.1238———
Sep 1, 2026Jul 30, 20260.12410.120.00-3.30%
Jun 3, 2026Apr 24, 2026-0.14907-0.68-0.53-356.16%
Apr 17, 2026Jan 31, 20260.1702-0.16-0.33-194.01%

Upgrades / downgrades

MMED analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026Jefferiesinit—Hold
Oct 8, 2026MizuhomainOutperformOutperform
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 24, 2026Truist Securitiesinit—Buy
Sep 3, 2026Morgan StanleymainOverweightOverweight
Sep 2, 2026CitigroupmainBuyBuy

About MiniMed Group, Inc.

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
minimed.com

News

Your note

Sign in to keep a note on MMED — it syncs with the Stock Master app.

Insider holders

MMED insider holders
InsiderRelationLatest transactionDateShares held
CHANDRASENA GILLIANOfficerStock Award(Grant)Oct 14, 2026174,545
DALLARA QUEChief Executive OfficerStock Award(Grant)Jun 30, 2026916,099
DENTON SHEILA AGeneral CounselStock Award(Grant)Sep 30, 202658,939
DIANATY ALIChief Technology OfficerStock Award(Grant)Oct 14, 2026326,266
EISENBERG GLENN ADirectorStock Award(Grant)Oct 8, 202625,684
GROSSMAN DONALD KEITHDirectorStock Award(Grant)Oct 8, 202625,684

Institution ownership

MMED institution ownership
Holder% heldSharesValueReported
Massachusetts Financial Services Co.2.96%8,334,738157.53MJun 29, 2026
Millennium Management Llc1.09%3,060,61557.85MJun 29, 2026
Citadel Advisors Llc1.02%2,865,70354.16MJun 29, 2026
Longaeva Partners L.P.1.00%2,812,97053.17MJun 29, 2026
Blackrock Inc.0.71%1,996,48937.73MJun 29, 2026
Sessa Capital IM, L.P.0.71%2,000,00037.80MJun 29, 2026

Fund ownership

MMED fund ownership
Holder% heldSharesValueReported
MFS SERIES TRUST XI-MFS Mid Cap Value Fund1.52%4,277,56780.85MJun 29, 2026
Fidelity Select PORT.s-Select Medical Technology and Devices PORT.0.66%1,850,00034.96MAug 30, 2026
MFS SERIES TRUST XIII-MFS New Discovery Value Fund0.32%888,54516.79MAug 30, 2026
MFS SERIES TRUST I-MFS New Discovery Fund0.31%866,94216.39MAug 30, 2026
First TRT Exch-Trd Fd.-First TRT US Eqy. Opportunities ETF0.29%813,14715.37MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF0.27%749,53214.17MSep 29, 2026